Karim Ouldim

1.0k total citations
43 papers, 384 citations indexed

About

Karim Ouldim is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Karim Ouldim has authored 43 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Genetics. Recurrent topics in Karim Ouldim's work include Colorectal Cancer Screening and Detection (9 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Karim Ouldim is often cited by papers focused on Colorectal Cancer Screening and Detection (9 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (6 papers). Karim Ouldim collaborates with scholars based in Morocco, France and United States. Karim Ouldim's co-authors include Laila Bouguenouch, Abdelaziz Sefiani, Hassan Ghazal, S. Atmani, M. Andrea Azcárate-Peril, Lekbir Baala, Asma Smahi, Arnold Münnich, S. Hadj‐Rabia and Christine Bodemer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Nutrients.

In The Last Decade

Karim Ouldim

34 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karim Ouldim Morocco 10 241 114 56 43 38 43 384
Lauren Weintraub United States 11 118 0.5× 52 0.5× 72 1.3× 25 0.6× 17 0.4× 28 408
Mohamed Sabry Egypt 12 196 0.8× 76 0.7× 16 0.3× 44 1.0× 30 0.8× 38 425
Maribel Forero‐Castro Colombia 8 87 0.4× 43 0.4× 31 0.6× 41 1.0× 36 0.9× 29 269
Philip S. Robinson United Kingdom 8 250 1.0× 106 0.9× 73 1.3× 18 0.4× 41 1.1× 13 518
Vera Gallo Italy 14 190 0.8× 169 1.5× 38 0.7× 22 0.5× 43 1.1× 31 561
Tomoo Osumi Japan 11 110 0.5× 31 0.3× 104 1.9× 26 0.6× 90 2.4× 54 374
Martin Farr Germany 14 254 1.1× 48 0.4× 39 0.7× 40 0.9× 12 0.3× 32 528
Anahita Mohseni Meybodi Iran 15 267 1.1× 250 2.2× 20 0.4× 67 1.6× 20 0.5× 66 582
Isaura Rigo United States 6 116 0.5× 20 0.2× 45 0.8× 47 1.1× 132 3.5× 12 402
Johanna M. Schuetz Canada 11 179 0.7× 66 0.6× 129 2.3× 8 0.2× 14 0.4× 20 431

Countries citing papers authored by Karim Ouldim

Since Specialization
Citations

This map shows the geographic impact of Karim Ouldim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Ouldim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Ouldim more than expected).

Fields of papers citing papers by Karim Ouldim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Ouldim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Ouldim. The network helps show where Karim Ouldim may publish in the future.

Co-authorship network of co-authors of Karim Ouldim

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Ouldim. A scholar is included among the top collaborators of Karim Ouldim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Ouldim. Karim Ouldim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouldim, Karim, et al.. (2024). Novel ABL1 mutation in a Moroccan CML patient with Imatinib resistance. Cancer Genetics. 288-289. 40–42.
2.
Bouguenouch, Laila, et al.. (2024). A novel homozygous missense variant identified in the myosin VIIA motor domain of a Moroccan patient with usher syndrome. Molecular Biology Reports. 51(1). 683–683.
3.
Bouguenouch, Laila, et al.. (2023). The Diagnosis and Genetic Mechanisms of Prader-Willi Syndrome: Findings From a Moroccan Population Study. Cureus. 15(4). e37866–e37866. 2 indexed citations
4.
Ouldim, Karim, Laila Bouguenouch, Ellen Kampman, et al.. (2022). Dietary Fat Intake and KRAS Mutations in Colorectal Cancer in a Moroccan Population. Nutrients. 14(2). 318–318. 7 indexed citations
5.
Hamdi, Salsabil, Laila Bouguenouch, Karim Ouldim, et al.. (2022). Review of prostate cancer genomic studies in Africa. Frontiers in Genetics. 13. 911101–911101. 3 indexed citations
6.
Bouguenouch, Laila, et al.. (2018). Molecular and presymptomatic analysis of a Moroccan Lynch syndrome family revealed a novel frameshift MLH1 germline mutation. The Turkish Journal of Gastroenterology. 29(6). 701–704. 2 indexed citations
7.
Bouguenouch, Laila, et al.. (2018). The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence. Genetic Testing and Molecular Biomarkers. 22(8). 492–497. 4 indexed citations
8.
Allali, Imane, Noureddine Boukhatem, Laila Bouguenouch, et al.. (2018). Gut microbiome of Moroccan colorectal cancer patients. Medical Microbiology and Immunology. 207(3-4). 211–225. 56 indexed citations
9.
Bouguenouch, Laila, et al.. (2018). GATA4 molecular screening and assessment of environmental risk factors in a Moroccan cohort with tetralogy of Fallot. African Health Sciences. 18(4). 922–922. 5 indexed citations
10.
Ouldim, Karim, et al.. (2017). Novel NKX2-5 germline mutation in a Moroccan child with transitional atrio-ventricular septal defect (tAVSD). The Turkish Journal of Pediatrics. 59(5). 610–613. 1 indexed citations
11.
Sayel, Hanane, et al.. (2017). The detection of a novel insertion mutation in exon 2 of the MEFV gene associated with familial mediterranean fever in a moroccan family. Human Genome Variation. 4(1). 17023–17023. 1 indexed citations
12.
Bouguenouch, Laila, Hanane Sayel, S. Bennis, et al.. (2016). Syndrome de Lynch: à propos d’un cas et revue de la litterature. Pan African Medical Journal. 24. 142–142. 2 indexed citations
13.
Chbani, Laïla, Karim Ouldim, S. Bennis, et al.. (2015). Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration. Diagnostic Pathology. 10(1). 77–77. 4 indexed citations
14.
Ouldim, Karim, et al.. (2014). Agénésie bilatérale des vésicules séminales et des canaux déférents. Canadian Urological Association Journal. 8(7-8). 490–490.
15.
16.
Jaouad, Imane Cherkaoui, et al.. (2012). The first mutations in the MYH gene reported in Moroccan colon cancer patients. Gene. 496(1). 55–58. 5 indexed citations
17.
Tahiri, Latifa, et al.. (2011). Multiple synostosis syndrome. Joint Bone Spine. 79(2). 198–198.
18.
Ouldim, Karim, et al.. (2010). Gonadal Dysgenesis 46, XX Associated with Mayer‐Rokitansky‐Kuster‐Hauser Syndrome: One Case Report. Obstetrics and Gynecology International. 2010(1). 847370–847370. 16 indexed citations
19.
Ouldim, Karim, et al.. (2008). Unexpected fertility and paternal UPD 22. Fertility and Sterility. 90(5). 2013.e13–2013.e15. 18 indexed citations
20.
Ratbi, Ilham, et al.. (2007). La mutation 35delG du gène de la connexine 26, une cause fréquente des surdités non syndromiques autosomiques récessives au Maroc. Archives de Pédiatrie. 14(5). 450–453. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026